{
    "clinical_study": {
        "@rank": "105759", 
        "arm_group": {
            "arm_group_label": "Group Japan", 
            "description": "Children less than five years of age, hospitalized for RV GE or AGE and children with outpatient or emergency room visits for RV GE or AGE, between November 2009 and October 2014 (i.e., before and after the introduction of RV vaccination in Japan) in any of the selected hospitals."
        }, 
        "brief_summary": {
            "textblock": "This study aims at assessing the impact of RV vaccination in hospitals in Nagoya City\n      (administrative district), Japan, where RV vaccines have been introduced since November 2011\n      and financial support for vaccination costs by Nagoya city, Japan have been implemented from\n      October 2012."
        }, 
        "brief_title": "Study to Assess the Impact of Vaccination on Hospitalizations and Outpatient Visits Due to Rotavirus Gastroenteritis", 
        "completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Infections, Rotavirus", 
        "condition_browse": {
            "mesh_term": [
                "Gastroenteritis", 
                "Rotavirus Infections"
            ]
        }, 
        "detailed_description": {
            "textblock": "The electronic admission database or any other applicable database of the hospital will be\n      reviewed to identify hospitalized children/children with outpatient visits/emergency room\n      visits, less than five years of age who had been diagnosed with acute gastroenteritis (AGE)\n      or RV GE either by the International Classification of Diseases and Related Health Problems\n      10th Revision (ICD 10) diagnostic code (AA00-AA09 for intestinal infectious diseases and\n      A08.0 for RV specific GE) or by RV positive rapid diagnosis kit results.\n\n      Note: The outcomes for the outpatient and emergency room visits will be assessed only in\n      case the data for outpatient and emergency room visits can be obtained from at least one of\n      the study centers."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        -  Children aged less than five years visiting hospitals for RV GE or AGE from 2009 to\n        2014, who live in the study area.\n\n        Exclusion Criteria:\n\n        -  Not applicable."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "5 Years", 
            "minimum_age": "N/A", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Children less than five years of age, hospitalized for RV GE or AGE and children with\n        outpatient or emergency room visits for RV GE or AGE, between November 2009 and October\n        2014 (i.e., before and after the introduction of RV vaccination in Japan) in any of the\n        selected hospitals."
            }
        }, 
        "enrollment": {
            "#text": "6000", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 21, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01733862", 
            "org_study_id": "116929"
        }, 
        "intervention": {
            "arm_group_label": "Group Japan", 
            "description": "Data sheet.", 
            "intervention_name": "Data collection", 
            "intervention_type": "Other"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Impact", 
            "Vaccination", 
            "Hospitalizations", 
            "Rotavirus gastroenteritis", 
            "Japan"
        ], 
        "lastchanged_date": "March 6, 2014", 
        "number_of_groups": "1", 
        "official_title": "A Study to Assess the Impact of Rotavirus Vaccination on Hospitalizations and Outpatient Visits Due to Rotavirus Gastroenteritis (RV GE) in Japan", 
        "overall_official": {
            "affiliation": "GlaxoSmithKline", 
            "last_name": "GSK Clinical Trials", 
            "role": "Study Director"
        }, 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "Japan: MHLW (Ministry of Health, Labour and Welfare)"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "measure": "Occurrence of RV GE hospitalizations among all hospitalized children aged less than five years.", 
                "safety_issue": "No", 
                "time_frame": "Up to 5 years."
            }, 
            {
                "measure": "Occurrence of RV GE hospitalizations among AGE hospitalizations in children less than five years of age.", 
                "safety_issue": "No", 
                "time_frame": "Up to 5 years."
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01733862"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Occurrence of RV GE hospitalizations by age group in children less than five years of age.", 
                "safety_issue": "No", 
                "time_frame": "Up to 5 years."
            }, 
            {
                "measure": "Occurrence of AGE hospitalizations among all hospitalized children aged less than five years.", 
                "safety_issue": "No", 
                "time_frame": "Up to 5 years."
            }, 
            {
                "measure": "Occurrence of outpatient visits for AGE among all outpatient visits in children less than five years of age.", 
                "safety_issue": "No", 
                "time_frame": "Up to 5 years."
            }, 
            {
                "measure": "Occurrence of outpatient visits for RV GE among all outpatient visits in children less than five years of age.", 
                "safety_issue": "No", 
                "time_frame": "Up to 5 years."
            }, 
            {
                "measure": "Occurrence of outpatient visits for RV GE among AGE outpatient visits in children less than five years of age.", 
                "safety_issue": "No", 
                "time_frame": "Up to 5 years."
            }, 
            {
                "measure": "Duration of hospitalizations for RV GE or AGE, overall, for each year, season in children less than five years of age.", 
                "safety_issue": "No", 
                "time_frame": "Up to 5 years."
            }, 
            {
                "measure": "Occurrence of hospitalizations for RV GE among all emergency visits for RV GE in children less than five years of age.", 
                "safety_issue": "No", 
                "time_frame": "Up to 5 years."
            }
        ], 
        "source": "GlaxoSmithKline", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "GlaxoSmithKline", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "January 2013", 
        "study_design": "Observational Model: Ecologic or Community, Time Perspective: Retrospective", 
        "study_type": "Observational", 
        "verification_date": "March 2014"
    }
}